Indo Boga Sukses Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Indo Boga Sukses Tbk. trades at Rp68 (market cap 556.54B, 1.74M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Indo Boga Sukses Tbk. is far larger — about 3.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Indo Boga Sukses Tbk. is more actively traded (1.74M versus 71K). Which is the better fit depends on your goals.
| IBOS | OBAT | |
|---|---|---|
Market Cap | 556.54B | 167.37B |
Volume | 1.74M | 71K |
Lot | 17.36K | 710 |
Turnover | 120.36M | 17.51M |
Average Price | 69.34 | 246.63 |
Value | 120.36M | 17.51M |
Indicative Equilibrium Price | 68 | 246 |
Indicative Equilibrium Volume | 1.07K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indo Boga Sukses Tbk (”the Company”) was established based on notarial deed No. 6 dated January 16, 2019 of Tabitha Sri Jeany, S.H, MKn., notary in Yogyakarta.
Read more on IBOS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →